23/03/2025
PharmaTher Holdings Ltd. is making significant strides toward FDA approval for its generic intravenous (IV) ketamine. This is a critical pharmather-holdings-ltd-closing-in-on-fda-approval-for-its-generic-intravenous-iv-ketaminedevelopment in the U.S. healthcare landscape, especially given the ongoin...